Innophos Holdings (IPHS) Tops Q2 EPS by 4c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/16/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- SanDisk upgraded at JPMorgan after investor day; shares climb
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
Innophos To Acquire Novel Ingredients To Create A Nearly $0.5 Billion Food, Health And Nutrition Platform
August 1, 2017 7:01 AM EDTCRANBURY, N.J., Aug. 1, 2017 /PRNewswire/ -- Innophos Holdings, Inc. (NASDAQ: IPHS) announced today that it has entered into a definitive merger agreement to acquire Novel Ingredients, a New Jersey-based provider of dietary supplement ingredient solutions primarily owned by GenNx360 Capital Partners, a New York-based private equity firm.Â
Under the terms of the merger agreement, Innophos will acquire all of the outstanding shares of Novel Ingredients for a total purchase price of $125 million (enterprise value), payable in cash. Â Innophos will fund the acquisition with borrowings under its existing credit facility.... More
Innophos Holdings, Inc. Reports Second-Quarter 2017 Results
August 1, 2017 7:00 AM EDTCRANBURY, N.J., Aug. 1, 2017 /PRNewswire/ --Â Innophos Holdings, Inc. (NASDAQ:Â IPHS) today announced its financial results for the second quarter ended June 30, 2017. In a separate press release, Innophos announced today that it has entered into a definitive merger agreement to acquire Novel Ingredients, a New Jersey-based provider of dietary supplement ingredient solutions.
Highlights
Q2 revenue and earnings performance exceeded expectations All segments showed positive year-over-year volume comparisons Delivered final $2 million of $16 million procurement savings pipeline from Phase 1 Operational Excellence initiatives H2 2017 on track to realize $5 million of... More